Neuropathic Pain in Patients With Cancer
Public ClinicalTrials.gov record NCT00474916. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2 Double-Blind Dose Escalation Study of KRN5500 for Neuropathic Pain in Patients With Cancer
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to collect beginning information on whether intravenous (IV) administration of KRN5500 is safe and effective for treatment of neuropathic pain in patients with cancer.
Study identification
- NCT ID
- NCT00474916
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 19 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 2006 (Type not available)
- Primary completion
- Mar 2009 (Actual)
- Completion
- Apr 2009 (Actual)
- Last update posted
- Aug 16, 2010
2006 – 2009
United States locations
- U.S. sites
- 11
- U.S. states
- 8
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Cancer Institute Medical Group | Los Angeles | California | 90025 | — |
| Ghassan Al-Jazayrly, M.D., Inc. | Los Angeles | California | 90027 | — |
| University of California / Irvine Chao Family Comprehensive Cancer Center | Orange | California | 92868 | — |
| Keog Pharma, Inc. | Jupiter | Florida | 33477 | — |
| Hematology and Oncology Specialists, LLC | Covington | Louisiana | 70433 | — |
| St. Agnes Healthcare, Inc | Baltimore | Maryland | 21229 | — |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | — |
| East Orange VA Medical Center | East Orange | New Jersey | 07018 | — |
| Duke University Medical Center | Durham | North Carolina | 27710 | — |
| Carolina Pain Institute, PA | Winston-Salem | North Carolina | 27103 | — |
| Huntsman Cancer Institute | Salt Lake City | Utah | 84112 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00474916, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 16, 2010 · Synced Nov 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00474916 live on ClinicalTrials.gov.